• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Enhanced Ex Vivo Plasmodium vivax Intraerythrocytic Enrichment and Maturation for Rapid and Sensitive Parasite Growth Assays.增强的体外 vivax 疟原虫红内期富集和成熟用于快速和敏感的寄生虫生长检测。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02519-17. Print 2018 Apr.
2
Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.间日疟原虫:用于测量新鲜和冷冻保存分离株中氯喹敏感性的同位素、PicoGreen 和显微镜检测法。
Exp Parasitol. 2006 Sep;114(1):34-9. doi: 10.1016/j.exppara.2006.02.006. Epub 2006 Mar 20.
3
An analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testing.一种评估间日疟原虫阶段特异性药物活性的分析方法:对体外药物敏感性测试的影响。
PLoS Negl Trop Dis. 2012;6(8):e1772. doi: 10.1371/journal.pntd.0001772. Epub 2012 Aug 7.
4
Assessment of in vitro sensitivity of Plasmodium vivax fresh isolates.间日疟原虫新鲜分离株的体外敏感性评估。
Asian Pac J Trop Biomed. 2011 Jan;1(1):49-53. doi: 10.1016/S2221-1691(11)60067-1.
5
Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.“反向氯喹”化合物对氯喹耐药恶性疟原虫和间日疟原虫分离株的体外疗效对比
Antimicrob Agents Chemother. 2015 Sep;59(9):5721-6. doi: 10.1128/AAC.01048-15. Epub 2015 Jul 6.
6
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.间日疟原虫crt-o的表达与寄生虫阶段有关,但与体外氯喹敏感性无关。
Antimicrob Agents Chemother. 2015 Nov 2;60(1):361-7. doi: 10.1128/AAC.02207-15. Print 2016 Jan.
7
Monitoring of Plasmodium vivax sensitivity to chloroquine in vitro in Thailand.泰国间日疟原虫对氯喹体外敏感性的监测
Trans R Soc Trop Med Hyg. 2003 Jul-Aug;97(4):435-7. doi: 10.1016/s0035-9203(03)90080-0.
8
Determinants of in vitro drug susceptibility testing of Plasmodium vivax.间日疟原虫体外药物敏感性试验的决定因素
Antimicrob Agents Chemother. 2008 Mar;52(3):1040-5. doi: 10.1128/AAC.01334-07. Epub 2008 Jan 7.
9
Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.通过流式细胞术对疟原虫体外药物敏感性进行定量分析。
Malar J. 2015 Oct 24;14:417. doi: 10.1186/s12936-015-0940-8.
10
Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance.亚甲蓝抑制了来自氯喹耐药性不断增加地区的间日疟原虫的无性发育。
J Antimicrob Chemother. 2015 Jan;70(1):124-9. doi: 10.1093/jac/dku326. Epub 2014 Aug 21.

引用本文的文献

1
The essential genome of reveals determinants of antimalarial susceptibility.疟原虫的核心基因组揭示了抗疟易感性的决定因素。 (注:原句中“of”后缺少具体所指对象,根据语境推测补充了“疟原虫”,以使句子逻辑完整)
Science. 2025 Feb 7;387(6734):eadq6241. doi: 10.1126/science.adq6241.
2
Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages.针对间日疟原虫前体红细胞期和血液期的强效AMA1特异性人单克隆抗体。
Nat Commun. 2024 Dec 4;15(1):10556. doi: 10.1038/s41467-024-53848-4.
3
The PvRBP2b-TfR1 interaction is not essential for reticulocytes invasion by Plasmodium vivax isolates from Cambodia.疟原虫结合蛋白2b(PvRBP2b)与转铁蛋白受体1(TfR1)的相互作用对于柬埔寨间日疟原虫分离株入侵网织红细胞并非必不可少。
NPJ Vaccines. 2024 Nov 22;9(1):232. doi: 10.1038/s41541-024-01031-7.
4
spleen-dependent protein 1 and its role in extracellular vesicles-mediated intrasplenic infections.脾依赖性蛋白 1 及其在外泌体介导的脾内感染中的作用。
Front Cell Infect Microbiol. 2024 May 17;14:1408451. doi: 10.3389/fcimb.2024.1408451. eCollection 2024.
5
Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein.人源单克隆抗体抑制表达间日疟原虫 Duffy 结合蛋白的转基因伯氏疟原虫的入侵。
Malar J. 2023 Dec 4;22(1):369. doi: 10.1186/s12936-023-04766-1.
6
The structure of a Plasmodium vivax Tryptophan Rich Antigen domain suggests a lipid binding function for a pan-Plasmodium multi-gene family.恶性疟原虫色氨酸丰富抗原结构域的结构提示一个泛疟原虫多基因家族具有脂质结合功能。
Nat Commun. 2023 Sep 14;14(1):5703. doi: 10.1038/s41467-023-40885-8.
7
Development of a Plasmodium vivax biobank for functional ex vivo assays.开发一种用于功能性离体检测的间日疟原虫生物库。
Malar J. 2023 Aug 31;22(1):250. doi: 10.1186/s12936-023-04668-2.
8
Culture and transfection: Two major bottlenecks in understanding biology.培养与转染:理解生物学过程中的两大主要瓶颈。
Front Microbiol. 2023 Apr 4;14:1144453. doi: 10.3389/fmicb.2023.1144453. eCollection 2023.
9
Protocols for Plasmodium gametocyte production in vitro: an integrative review and analysis.体外疟原虫配子体生产的方案:综合回顾与分析。
Parasit Vectors. 2022 Dec 5;15(1):451. doi: 10.1186/s13071-022-05566-3.
10
Diverse Malaria Presentations across National Institutes of Health South Asia International Center for Excellence in Malaria Research Sites in India.在印度的美国国立卫生研究院南亚国际疟疾卓越研究中心,疟疾呈现出多种不同的表现形式。
Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):107-117. doi: 10.4269/ajtmh.21-1344.

本文引用的文献

1
Long-term in vitro culture of Plasmodium vivax isolates from Madagascar maintained in Saimiri boliviensis blood.马达加斯加间日疟原虫分离株在玻利维亚松鼠猴血中长期体外培养。
Malar J. 2017 Nov 3;16(1):442. doi: 10.1186/s12936-017-2090-7.
2
Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.检测柬埔寨地区分离的 vivax 疟原虫对药物的体外敏感性。
Malar J. 2017 Sep 30;16(1):392. doi: 10.1186/s12936-017-2034-2.
3
Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax.人类间日疟原虫在新大陆人群中的全基因组多样性与分化
PLoS Negl Trop Dis. 2017 Jul 31;11(7):e0005824. doi: 10.1371/journal.pntd.0005824. eCollection 2017 Jul.
4
Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.恶性疟原虫环胺抗性位点(PfCARL),一种针对两类不同化合物的抗性机制。
ACS Infect Dis. 2016 Nov 11;2(11):816-826. doi: 10.1021/acsinfecdis.6b00025. Epub 2016 Apr 7.
5
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.通过优化 2-氨基哒嗪系列化合物在寄生虫生命周期中的水溶性和效力,鉴定出一种有潜力的抗疟药物候选物。
J Med Chem. 2016 Nov 10;59(21):9890-9905. doi: 10.1021/acs.jmedchem.6b01265. Epub 2016 Oct 26.
6
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria.一种具有改善类药性质的基于三唑并嘧啶的二氢乳清酸脱氢酶抑制剂,用于疟疾的治疗和预防。
ACS Infect Dis. 2016 Dec 9;2(12):945-957. doi: 10.1021/acsinfecdis.6b00144. Epub 2016 Oct 4.
7
Challenges for malaria elimination in Brazil.巴西消除疟疾面临的挑战。
Malar J. 2016 May 20;15(1):284. doi: 10.1186/s12936-016-1335-1.
8
Improved light microscopy counting method for accurately counting Plasmodium parasitemia and reticulocytemia.用于准确计数疟原虫血症和网织红细胞血症的改良光学显微镜计数方法。
Am J Hematol. 2016 Aug;91(8):852-5. doi: 10.1002/ajh.24383. Epub 2016 May 24.
9
Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.用于间日疟原虫疟疾的即时检验G6PD诊断方法是一项临床和公共卫生的紧迫需求。
BMC Med. 2015 Dec 14;13:296. doi: 10.1186/s12916-015-0531-0.
10
Improvement of culture conditions for long-term in vitro culture of Plasmodium vivax.间日疟原虫长期体外培养培养条件的改进
Malar J. 2015 Aug 5;14:297. doi: 10.1186/s12936-015-0815-z.

增强的体外 vivax 疟原虫红内期富集和成熟用于快速和敏感的寄生虫生长检测。

Enhanced Ex Vivo Plasmodium vivax Intraerythrocytic Enrichment and Maturation for Rapid and Sensitive Parasite Growth Assays.

机构信息

Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.

出版信息

Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02519-17. Print 2018 Apr.

DOI:10.1128/AAC.02519-17
PMID:29378713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5913983/
Abstract

chloroquine resistance has been documented in nearly every region where this malaria-causing parasite is endemic. Unfortunately, resistance surveillance and drug discovery are challenging due to the low parasitemias of patient isolates and poor parasite survival through maturation that reduce the sensitivity and scalability of current antimalarial assays. Using cryopreserved patient isolates from Brazil and fresh patient isolates from India, we established a robust enrichment method for parasites. We next performed a medium screen for formulations that enhance survival. Finally, we optimized an isotopic metabolic labeling assay for measuring maturation and its sensitivity to antimalarials. A KCl Percoll density gradient enrichment method increased parasitemias from small-volume isolates by an average of >40-fold. The use of Iscove's modified Dulbecco's medium for culture approximately doubled the parasite survival through maturation. Coupling these with [H]hypoxanthine metabolic labeling permitted sensitive and robust measurements of parasite maturation, which was used to measure the sensitivities of Brazilian isolates to chloroquine and several novel antimalarials. These techniques can be applied to rapidly and robustly assess the isolate sensitivities to antimalarials for resistance surveillance and drug discovery.

摘要

氯喹耐药性已在几乎所有地方性疟原虫流行的地区得到证实。不幸的是,由于患者分离物的低寄生虫血症和成熟过程中寄生虫存活率低,导致耐药性监测和药物发现具有挑战性,这降低了当前抗疟药物检测的敏感性和可扩展性。我们使用来自巴西的冷冻患者分离物和来自印度的新鲜患者分离物,建立了一种有效的寄生虫富集方法。接下来,我们进行了中筛,以确定能提高存活率的配方。最后,我们优化了一种同位素代谢标记测定法来测量成熟度及其对抗疟药物的敏感性。KCl 聚蔗糖密度梯度富集法使小体积分离物中的寄生虫血症平均增加了>40 倍。使用 Iscove 的改良杜尔贝科培养基进行培养使寄生虫通过成熟的存活率增加了约两倍。将这些方法与[H]次黄嘌呤代谢标记相结合,可灵敏而稳健地测量寄生虫的成熟度,并用其来测量巴西分离物对氯喹和几种新型抗疟药物的敏感性。这些技术可用于快速而稳健地评估抗疟药物对分离物的敏感性,以进行耐药性监测和药物发现。